You can now read 10 articles in a month for free on Read as much as you want anywhere and anytime for just 99¢.

The Boston Globe


mass. mover

Sales of AMAG injection soar 33 percent

AMAG reported record sales of its Feraheme injection.


AMAG reported record sales of its Feraheme injection.

Continue reading below

AMAG Pharmaceuticals reported a third-quarter net loss of $145,000, or 1 cent per share, compared with a net loss of $4 million, or 19 cents, a year earlier. The Waltham-based pharmaceutical company also said US sales of its Feraheme injection, which treats iron deficiency anemia in adults, were up 33 percent. During the quarter, AMAG also began promoting MuGard Mucoadhesive Oral Wound Rinse, which it licensed from Access Pharmaceuticals Inc. earlier this year.

You have reached the limit of 10 free articles in a month

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week